Investing
This news comes just months after it closed its $25 million Series B round.
Since launching its SedaKit for Digital Sedation product in June 2019, the Belgian company said more than 60,000 patients have used its digital therapy.
Walk-through cancer diagnoses and robotics muscles among the six projects aimed to transform NHS healthcare delivery.
Biofourmis has restructured its business to pursue its original focus on data-driven patient monitoring alongside its more recent interest in standalone and companion digital therapeutics.
The funding will also help get much-needed therapies to patients faster.
The company's implanted product acts as a closed-loop system that monitors and responds to brain activity by automatically delivering stimulation prior to the start of a seizure.
The latest round was led by Felicis Ventures. As part of that deal, Sundeep Peechu, managing director at the VC firm, will sit on the PicnicHealth board.
The company said it has grown its business by 400% in the last three months alone.
The company was founded in 2011 and is looking to go public on the Nasdaq market.